Symbol | Exchange | Currency |
|---|
Last year was a remarkable period for companies to go public via special purpose acquisition companies (SPACs). In 2020, in fact, there were 248 completed deals in the US. In 2019,...
Over the past several quarters, a large number of companies have gone public in the US. Many, such as Airbnb (NASDAQ:ABNB), Asana (NYSE:ASAN), DoorDash (NYSE:DASH), Jfrog...
Special purpose acquisition companies (SPACs), which we recently covered}}, are currently among the hottest ways for company's to go public in equity markets. In a nutshell, a SPAC...
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Neutral | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 29.25 | 30.00 | 30.00 | 0.00 | 0.00% | 21.44K | London | |||
| 116.50 | 119.50 | 116.00 | -0.75 | -0.64% | 73.78K | London | |||
| 6.55 | 6.55 | 6.55 | 0.00 | 0.00% | 43.04K | London | |||
| 74.90 | 76.40 | 73.40 | +0.30 | +0.40% | 831.17K | London | |||
| 126.50 | 126.92 | 125.58 | 0.00 | 0.00% | 66.26M | London | |||
| 26.00 | 26.00 | 26.00 | 0.00 | 0.00% | 0.00 | London | |||
| 244.80 | 246.00 | 244.80 | 0.00 | 0.00% | 0.00 | London | |||
| 3,700.00 | 3,730.00 | 3,590.00 | +75.0 | +2.07% | 30.95K | London | |||
| 537.30 | 537.30 | 524.50 | +10.70 | +2.03% | 23.66M | London | |||
| 1.23 | 1.23 | 1.23 | -0.10 | -7.55% | 1.25M | London | |||
| 238.00 | 241.00 | 209.00 | +13.00 | +5.78% | 1.63M | London | |||
| 114.68 | 115.40 | 112.80 | +0.50 | +0.44% | 19.02M | London | |||
| 35.50 | 35.50 | 35.50 | 0.00 | 0.00% | 533.90K | London | |||
| 255.40 | 256.50 | 246.90 | +8.80 | +3.57% | 24.12M | London | |||
| 668.50 | 670.00 | 625.00 | +27.50 | +4.29% | 396.96K | London |